AADAC anticorps (C-Term)
Aperçu rapide pour AADAC anticorps (C-Term) (ABIN452700)
Antigène
Voir toutes AADAC AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- This antibody detects Arylacetamide deacetylase at C-term.
-
Réactivité croisée (Details)
- Species reactivity (tested):Human
-
Purification
- Prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS
-
Immunogène
- KLH conjugated synthetic peptide selected from the C-terminal region of human AADAC
-
-
-
-
Indications d'application
-
ELISA: 1: 1,000. Western blot: 1: 50 - 1: 100.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.52 % (W/V) sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2 - 8 °C for up to one month or (in aliquots) at -20 °C.
-
-
- AADAC (Arylacetamide Deacetylase (Esterase) (AADAC))
-
Autre désignation
- AADAC
-
Sujet
- Microsomal arylacetamide deacetylase (AADAC) competes against the activity of cytosolic arylamine N-acetyltransferase which catalyzes the N-or O-acetylation of various arylamine and heterocyclic amine substrates and is able to bioactivate several known carcinogens. Arylacetamide deacetylation by AADAC is also important in the metabolic activation of some arylamine substrates to carcinogens.Synonyms: CES5A1, DAC, arylacetamide deacetylase
-
ID gène
- 13
-
NCBI Accession
- NP_001077
-
UniProt
- P22760
Antigène
-